Logo image of WEED.CA

CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

TSX:WEED - Toronto Stock Exchange - CA1380357048 - Common Stock - Currency: CAD

1.54  +0.02 (+1.32%)

Fundamental Rating

2

Taking everything into account, WEED scores 2 out of 10 in our fundamental rating. WEED was compared to 35 industry peers in the Pharmaceuticals industry. While WEED seems to be doing ok healthwise, there are quite some concerns on its profitability. WEED has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

WEED had negative earnings in the past year.
WEED had a negative operating cash flow in the past year.
In the past 5 years WEED always reported negative net income.
WEED had a negative operating cash flow in each of the past 5 years.
WEED.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of -65.18%, WEED is doing worse than 85.71% of the companies in the same industry.
With a Return On Equity value of -122.76%, WEED is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -65.18%
ROE -122.76%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
WEED.CA Yearly ROA, ROE, ROICWEED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

The Gross Margin of WEED (30.30%) is comparable to the rest of the industry.
WEED does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEED.CA Yearly Profit, Operating, Gross MarginsWEED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WEED has been increased compared to 1 year ago.
The number of shares outstanding for WEED has been reduced compared to 5 years ago.
The debt/assets ratio for WEED has been reduced compared to a year ago.
WEED.CA Yearly Shares OutstandingWEED.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
WEED.CA Yearly Total Debt VS Total AssetsWEED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -12.75, we must say that WEED is in the distress zone and has some risk of bankruptcy.
WEED has a worse Altman-Z score (-12.75) than 85.71% of its industry peers.
A Debt/Equity ratio of 0.64 indicates that WEED is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.64, WEED is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z -12.75
ROIC/WACCN/A
WACC11.68%
WEED.CA Yearly LT Debt VS Equity VS FCFWEED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 3.12 indicates that WEED has no problem at all paying its short term obligations.
WEED's Current ratio of 3.12 is fine compared to the rest of the industry. WEED outperforms 77.14% of its industry peers.
WEED has a Quick Ratio of 2.10. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of WEED (2.10) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.12
Quick Ratio 2.1
WEED.CA Yearly Current Assets VS Current LiabilitesWEED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.57% over the past year.
WEED shows a decrease in Revenue. In the last year, the revenue decreased by -9.49%.
WEED shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.57% yearly.
EPS 1Y (TTM)34.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.72%
Revenue 1Y (TTM)-9.49%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-6.22%

3.2 Future

WEED is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.29% yearly.
WEED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.64% yearly.
EPS Next Y89.5%
EPS Next 2Y38.49%
EPS Next 3Y23.41%
EPS Next 5Y15.29%
Revenue Next Year7.13%
Revenue Next 2Y6.99%
Revenue Next 3Y5.97%
Revenue Next 5Y4.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WEED.CA Yearly Revenue VS EstimatesWEED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
WEED.CA Yearly EPS VS EstimatesWEED.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WEED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WEED is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED.CA Price Earnings VS Forward Price EarningsWEED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED.CA Per share dataWEED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as WEED's earnings are expected to grow with 23.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.49%
EPS Next 3Y23.41%

More info and screens

0

5. Dividend

5.1 Amount

WEED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANOPY GROWTH CORP

TSX:WEED (7/17/2025, 7:00:00 PM)

1.54

+0.02 (+1.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-30 2025-05-30/bmo
Earnings (Next)08-08 2025-08-08/bmo
Inst Owners8.19%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner ChangeN/A
Market Cap325.63M
Analysts46.67
Price Target2.82 (83.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-153.89%
Min EPS beat(2)-206.63%
Max EPS beat(2)-101.15%
EPS beat(4)0
Avg EPS beat(4)-194.79%
Min EPS beat(4)-240.27%
Max EPS beat(4)-101.15%
EPS beat(8)1
Avg EPS beat(8)-180.52%
EPS beat(12)1
Avg EPS beat(12)-197.59%
EPS beat(16)4
Avg EPS beat(16)-139.13%
Revenue beat(2)2
Avg Revenue beat(2)6.85%
Min Revenue beat(2)6.06%
Max Revenue beat(2)7.65%
Revenue beat(4)2
Avg Revenue beat(4)1.32%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)4.78%
Revenue beat(12)6
Avg Revenue beat(12)0.48%
Revenue beat(16)7
Avg Revenue beat(16)-2.12%
PT rev (1m)-22.18%
PT rev (3m)-26.66%
EPS NQ rev (1m)-25.7%
EPS NQ rev (3m)-25.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.47%
Revenue NQ rev (1m)-9.49%
Revenue NQ rev (3m)-9.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.21
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)-5.66
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS1.27
BVpS2.3
TBVpS1.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.18%
ROE -122.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.3%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.16%
Cap/Sales 4.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.12
Quick Ratio 2.1
Altman-Z -12.75
F-Score5
WACC11.68%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.72%
EPS Next Y89.5%
EPS Next 2Y38.49%
EPS Next 3Y23.41%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-9.49%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-6.22%
Revenue Next Year7.13%
Revenue Next 2Y6.99%
Revenue Next 3Y5.97%
Revenue Next 5Y4.64%
EBIT growth 1Y48.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.26%
EBIT Next 3Y30.78%
EBIT Next 5Y20.32%
FCF growth 1Y38.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.21%
OCF growth 3YN/A
OCF growth 5YN/A